GLP-1/A1AT fusion proteins (Alteogen)

N/A

Report date: 2025/01/26 18:00:52

Base Information

Drug NameGLP-1/A1AT fusion proteins (Alteogen)
Drug Alias Nameglucagon-like peptide 1/alpha-1 antitrypsin fusion proteins (Alteogen)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsMetabolic DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlteogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlteogen Inc
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A